Lansforsakringar Fondforvaltning AB publ Buys 1,264 Shares of Axon Enterprise, Inc $AXON

Lansforsakringar Fondforvaltning AB publ grew its position in Axon Enterprise, Inc (NASDAQ:AXON) by 5.5% in the first quarter, according to its most recent filing with the SEC. The fund owned 24,263 shares of the biotechnology company’s stock after acquiring an additional 1,264 shares during the period. Lansforsakringar Fondforvaltning AB publ’s holdings in Axon Enterprise were worth $10,304,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Creative Financial Designs Inc. ADV acquired a new position in Axon Enterprise in the 4th quarter valued at approximately $28,000. Sound Income Strategies LLC lifted its holdings in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares during the period. Camelot Portfolios LLC bought a new stake in shares of Axon Enterprise in the fourth quarter worth $30,000. AlphaCentric Advisors LLC bought a new stake in shares of Axon Enterprise in the fourth quarter worth $34,000. Finally, Lodestone Wealth Management LLC acquired a new stake in Axon Enterprise in the fourth quarter valued at $35,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: News that President Trump reportedly bought up to $5 million of Axon stock, followed by an ICE request for a potential $220 million TASER contract, has sparked speculation that demand for Axon’s public-safety equipment could accelerate. Trump bought up to $5M in Axon stock. ICE sought a $220M Taser deal weeks later
• Positive Sentiment: Axon’s latest results also remain a support for the stock, with first-quarter revenue up 33.7% year over year and earnings slightly ahead of expectations, reinforcing the company’s growth narrative. Axon Enterprise jumps as investors react to disclosure-linked contract narrative and strong operating momentum
• Positive Sentiment: Axon’s Software & Services business is also gaining traction, with rising digital evidence demand, network users, and Dedrone growth helping support investor confidence in longer-term recurring revenue. AXON Gains From Strength in Software & Services Unit: Can the Momentum Sustain?
• Positive Sentiment: Several analyst views remain constructive, including recent buy/overweight reiterations and price targets well above recent trading levels. Northland Securities Reaffirms Their Buy Rating on Axon Enterprise (AXON)

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $593.96 on Thursday. The stock has a market cap of $47.87 billion, a price-to-earnings ratio of 238.54, a PEG ratio of 11.44 and a beta of 1.38. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The firm’s 50-day simple moving average is $429.96 and its 200 day simple moving average is $481.36.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.01. The firm had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.90 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business’s revenue was up 33.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.47 EPS. As a group, research analysts anticipate that Axon Enterprise, Inc will post 1.63 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Axon Enterprise news, CRO Cameron Brooks sold 1,242 shares of the business’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $621,000.00. Following the sale, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. The trade was a 2.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 13,000 shares of the business’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $488.45, for a total value of $6,349,850.00. Following the sale, the president owned 169,125 shares in the company, valued at approximately $82,609,106.25. The trade was a 7.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 48,989 shares of company stock valued at $24,090,083. Company insiders own 4.20% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on the company. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. Zacks Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 19th. Barclays lowered their price objective on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a research report on Friday, May 8th. Citizens Jmp reiterated a “market outperform” rating and issued a $700.00 target price on shares of Axon Enterprise in a report on Thursday, June 25th. Finally, JPMorgan Chase & Co. upped their target price on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $712.75.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.